Abstract
Experimental strategies have been developed to correct point mutations using chimeric oligonucleotides composed of RNA and DNA. We used these RNA-DNA oligonucleotides to correct a point mutation in mouse tyrosinase, a key enzyme for melanin synthesis and pigmentation. Melanocytes derived from albino mice contain a homozygous point mutation (TGT→TCT) in the tyrosinase gene, resulting in an amino acid change from Cys→Ser. Correction of this point mutation results in the restoration of tyrosinase activity and melanin synthesis, thus changing the pigmentation of the cells. Upon transfection of the RNA-DNA oligonucleotide to albino melanocytes, we detected black-pigmented cells and isolated multiple single clones. All black-pigmented clones exhibited a correction of the point mutation in a single allele of the tyrosinase gene. A full-length tyrosinase was detected by an antityrosinase antibody, and the enzymatic activity was restored in all converted black-pigmented clones. Only degraded fragments were detected in albino cells due to proteolytic cleavage of mutant tyrosinase. The phenotype and genotype of converted black-pigmented clones was stable. These results demonstrate a permanent and stable gene correction by the RNA-DNA oligonucleotide at the level of genomic sequence, protein, and phenotypic change by clonal analysis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout





Similar content being viewed by others
References
Yoon, K., Cole-Strauss, A., and Kmiec, E.B. 1996. Targeted gene correction of episomal DNA in mammalian cells mediated by a chimeric RNA/DNA oligonucleotide. Proc. Natl. Acad. Sci. USA 93: 2071– 2076.
Cole-Strauss, A., Yoon, K., Xiang, Y., Byrne, B.C., Rice, M.C., Gryn, J. et al. 1996. Correction of the mutation responsible for sickle cell anemia by an RNA/DNA oligonculeotide. Science 273: 1386– 1389.
Xiang, Y., Cole-Strauss, A., Yoon, K., Gryn, J., and Kmiec, E.B. 1997. Targeted gene conversion in a mammalian CD34+-enriched cell population using a chimeric RNA/DNA oligonucleotide. J. Mol. Med. 75: 829–835.
Kren, B.T., Cole-Strauss, A., Kmiec, E.B., and Steer, C.J. 1997. Targeted nucleotide exchange in the alkaline phosphatase gene of HuH-7 cells mediated by a chimeric RNA/DNA oligonucleotide. Hepatology 25: 1462–1468.
Kren, B.T., Bandyopadhyay, P., and Steer, C.J. 1998. In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides. Nat. Med. 4: 285–290.
Kotani, H. and Kmiec, E.B. 1994. A role for RNA synthesis in homologous pairing events. Mol. Cell. Biol . 14: 6097–6106.
Kotani, H. and Kmiec, E.B. 1994. Transcription activates RecA-promoted homologous pairing of nucleosomal DNA. Mol. Cell. Biol. 14: 1949–1955.
Kotani, H., Germann, M.W., Andrus, A., Vinayak, R., Mullah, B., and Kmiec, E.B. 1996. RNA facilitates RecA-mediated DNA pairing and strand transfer between molecules bearing limited regions of homology. Mol. Gen. Genet. 250: 626– 634.
Modrich, P. and Lahue, R. 1996. Mismatch repair in replication, fidelity, genetic recombination and cancer biology. Annu. Rev. Biochem. 65: 101– 133.
Woolf, T.M. 1998. Therapeutic repair of mutated nucleic acid sequences. Nat. Biotechnol. 16: 341– 344.
Yanez, R.J. and Porter, A.C.G. 1998. Therapeutic gene targeting. Gene Ther. 5: 149– 159.
Thomas, K.R. and Capecchi, M.R. 1997. Recombinant DNA technique and sickle cell anemia research. Science 275: 1404–1405.
Stasiak, A., West, S.C., and Egelman, E.H. 1997. Sickle cell anemia research and a recombinant DNA technique. Science 277: 460–462.
Strauss, M. 1998. The site-specific correction of genetic defects. Nat. Med. 4: 274–275.
Halaban, R. and Moellmann, G. 1993. White mutants in mice shedding light on humans. J. Invest. Dermatol. 100: 176S–185S.
del Marmol, V. and Beermann, F. 1996 . Tyrosinase and related proteins in mammalian pigmentation. FEBS Lett. 381: 165–168.
Shibahara, S., Okinaga S., Tomkta, Y., Takeda, A., Yamamoto, H., Sato, M. et al. 1990. A point mutation in the tyrosinase gene of BALB/c albino mouse causing the cysteine-serine substitution at position 85. Eur. J. Biochem. 189: 455–461.
Beermann, F., Ruppert, S., Hummler, E., Bosch, F.X., Muller, G., Ruther, U. et al. 1990. Rescue of the albino phenotype by introduction of a functional tyrosinase gene into mice. EMBO J. 9: 2819– 2826.
Tanaka, S., Yamamoto, H., Takeuchi, S., and Takeuchi, T. 1990. Melanization in albino mice transformed by introducing cloned mouse tyrosinase gene. Development 108: 223–227.
Huszar, D., Sharpe, A., Hashmi, S., Bouchard, B., Houghton, A., and Jaenisch, R. 1991. Generation of pigmented stripes in albino mice by retroviral marking of neural crest melanoblasts. Development 113: 653–660.
Jackson, I.J. and Bennett, D.C. 1990. Identification of the albino mutation of mouse tyrosinase by analysis of an in vitro revertant. Proc. Natl. Acad. Sci. USA 87: 7010– 7014.
Bennet, D.C., Cooper, P.J., Dexter, T.J., Delvin, L.M., Heasman, J., and Nester, B. 1989. Cloned mouse melanocyte line carrying the germline mutations albino and brown: complementation in culture. Development 105: 379–385 .
Jimenez, M., Tsukamoto, K., and Hearing, V.J. 1991, Tyrosinases from two different loci are expressed by normal and by transformed melanocytes. J. Biol. Chem. 266: 1147–1156.
Halaban, R., Moellmann, G., Tamura, A., Kwon, B.S., Kuklinska, E., Pomerantz, S.H. et al. 1988. Tyrosinase of murine melanocytes with mutations at the albino locus. Proc. Natl. Acad. Sci. USA 85: 7241–7245.
Boissy, R.E., Liu, Y-Y., Medrano, E.E., and Norland, J.J. 1991, Structural aberration of the rough endoplasmic reticulum and melanosome compartmentalization in long-term cultures of melanocytes from vitiligo patients. J. Invest. Dermatol. 97: 395– 404.
Santana, E., Peritz, A.E., Subramanian I., Uitto, J., and Yoon, K. 1998. Different frequency of gene targeting events by the RNA-DNA oligonucleotide among epithelial cells. J. Invest. Dermatol. 111: 101– 106.
Acknowledgements
We thank A.E. Peritz for synthesis and purification of oligonucleotides used in this work. We thank D.C. Bennet, V.J. Hearing, and H. Yamamoto for generously providing the melan-c and melan-a cells, tyrosinase antibody, and tyrosinase cDNA. This work was supported by NIH grant R01AR44350.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Alexeev, V., Yoon, K. Stable and inheritable changes in genotype and phenotype of albino melanocytes induced by an RNA-DNA oligonucleotide. Nat Biotechnol 16, 1343–1346 (1998). https://doi.org/10.1038/4322
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1038/4322
This article is cited by
-
The albino mutation of tyrosinase alters ocular angiogenic responsiveness
Angiogenesis (2013)
-
Single-strand DNA-mediated targeted mutagenesis of genomic DNA in early mouse embryos is stimulated by Rad51/54 and by Ku70/86 inhibition
Gene Therapy (2008)
-
Effective oligonucleotide-mediated gene disruption in ES cells lacking the mismatch repair protein MSH3
Gene Therapy (2006)
-
Oligonucleotide-directed gene repair in wheat using a transient plasmid gene repair assay system
Plant Cell Reports (2006)
-
Liver transplantation and new therapeutic approaches for familial amyloidotic polyneuropathy (FAP)
Medical Molecular Morphology (2005)


